ArticleBMC nephrology2026

Comparison of efficacy and safety among four therapeutic regimens in primary membranous nephropathy with high anti-PLA2R antibody titers: a single-center retrospective cohort study.

Yuxiu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.